国际静脉血栓栓塞症患者结局测量标准集的制定:国际健康结局测量联盟共识推荐
国际健康结局测量联盟组建静脉血栓栓塞症专家与患者代表工作组,制定标准化最小结局及测量工具集以融入临床实践并支持决策与质量基准比较。共选定15项核心结局,归入患者报告结局、疾病长期后果、疾病特异性并发症和治疗相关并发症四个领域,适用于16岁及以上所有静脉血栓栓塞症患者,并配套测量工具包与预设时间点及级联选择加入系统。
要点
- 选定15项对患者和医护人员重要的核心结局,归入四个领域。
- 结局与测量工具设计适用于16岁及以上所有静脉血栓栓塞症患者。
- 测量工具包含最少条目并在预设时间点测量,另设级联选择加入系统。
核心结论
- 该结局与测量工具集将促进以患者为中心的结局在日常实践中的应用。
研究设计与样本
- 国际健康结局测量联盟组建静脉血栓栓塞症专家与患者代表国际工作组,制定标准化最小结局及测量工具集。
主要发现
- 选定15项对患者和医护人员重要的核心结局,归入患者报告结局、疾病长期后果、疾病特异性并发症和治疗相关并发症四个领域。
关键数值与推荐
- 结局与结局测量设计适用于16岁及以上所有静脉血栓栓塞症患者。
- 测量工具包被选入核心标准集,含在预设时间点测量的最少条目数,覆盖全部核心结局。
- 通过级联选择加入系统可向使用者引入额外测量,按需进一步评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The International Consortium for Health Outcomes Measurement assembled an international working group of venous thromboembolism experts and patient representatives to develop a standardised minimum set of outcomes and outcome measurements for integration into clinical practice and potentially research to support clinical decision making and benchmarking of quality of care. 15 core outcomes important to patients and health-care professionals were selected and categorised into four domains: patient-reported outcomes, long term consequences of the disease, disease-specific complications, and treatment-related complications. The outcomes and outcome measures were designed to apply to all patients with venous thromboembolism aged 16 years or older. A measurement tool package was selected for inclusion in the core standard set, with a minimum number of items to be measured at predefined timepoints, which capture all core outcomes. Additional measures can be introduced to the user by a cascade opt-in system that allows for further assessment if required. This set of outcomes and measurement tools will facilitate the implementation of the use of patient-centred outcomes in daily practice.
引用
- Gwozdz AM, de Jong CMM, Fialho LS, et al. Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation. Lancet Haematol. 2022. PMID: 36055334. doi:10.1016/S2352-3026(22)00215-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。